RecruitingPhase 4NCT06007547
Prophylactic Minimally Invasive Surfactant Evaluation
Sponsor
Endeavor Health
Enrollment
200 participants
Start Date
Jan 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to explore the question: Does prophylactic administration of exogenous surfactant in the delivery room, using a minimally-invasive technique, improve outcome in preterm infants 22-29 weeks' gestation compared to rescue treatment using the same technique?
Eligibility
Max Age: 15 Minutes
Inclusion Criteria2
- Gestational age \<30 weeks
- Antenatal consent from Parent
Exclusion Criteria2
- Congenital anomalies
- Alternate cause of respiratory distress
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGPoractant Alfa
Poractant alfa (Curosurf) 200mg/kg administered under direct laryngoscopy using a surfactant instillation catheter
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06007547
Related Trials
Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods in Preterm Babies
NCT068800161 location
Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care
NCT066435981 location
Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa
NCT065545228 locations
Neonatal Data and Biobank to Study Factors Influencing Development in Preterm Infants Born at <32 Weeks' Gestation and/or <1500 g Birth Weight
NCT074909121 location
Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting
NCT073447141 location